Literature DB >> 14318586

FAILURE OF PROLONGED SULFONYLUREA ADMINISTRATION TO ENHANCE INSULOGENIC RESPONSE TO GLYCEMIC STIMULUS.

H S SELTZER, E W ALLEN, M T BRENNAN.   

Abstract

Entities:  

Keywords:  BLOOD SUGAR; DOGS; EXPERIMENTAL LAB STUDY; HISTOLOGY; INSULIN; ISLANDS OF LANGERHANS; PHARMACOLOGY; TOLBUTAMIDE

Mesh：

Substances：

Year:  1965        PMID： 14318586     DOI： 10.2337/diab.14.7.392

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  8 in total

1.  Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.

Authors:  E Bonora; P Moghetti; M Querena; M Zenere; V Cacciatori; F Tosi; D Travia; G Zoppini; M Muggeo
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

2.  The role of carbohydrate and oral agents in the treatment of diabetes mellitus.

Authors:  W D Odell
Journal:  Calif Med       Date:  1973-10

Review 3.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

4.  Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.

Authors:  H S Seltzer; E W Allen; A L Herron; M T Brennan
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

5.  An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals.

Authors:  J C Dunbar; P P Foà
Journal:  Diabetologia       Date:  1974-02       Impact factor: 10.122

6.  Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.

Authors:  P Serradas; D Bailbé; B Portha
Journal:  Diabetologia       Date:  1989-08       Impact factor: 10.122

7.  The regulation of glucose-induced insulin secretion by pre-stimulus glucose level and tolbutamide in normal man.

Authors:  M A Pfeifer; R J Graf; J B Halter; D Porte
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

8.  Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.

Authors:  J P Hosker; M A Burnett; E G Davies; E A Harris; R C Turner
Journal:  Diabetologia       Date:  1985-11       Impact factor: 10.122
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.